Reality check: should we try to detect and isolate vancomycin-resistant enterococci patients?
Antimicrobial resistance, including vancomycin resistance in enterococci (VRE), is a growing problem in healthcare facilities. This "Reality Check" session focused on the question of whether we should try to detect and isolate patients colonized or infected with VRE.
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, United States Department of Health and Human Services, Atlanta, Georgia, USA.
B
B
Ostrowsky
J T
JT
Steinberg
B
B
Farr
A H
AH
Sohn
R L
RL
Sinkowitz-Cochran
W R
WR
Jarvis
D001291:Attitude of Health Personnel; D002487:Centers for Disease Control and Prevention, U.S.; D003428:Cross Infection / Q000517:prevention & control*; D016984:Enterococcus faecium / Q000187:drug effects*; D019983:Guideline Adherence; D006801:Humans; D017053:Infection Control / Q000379:methods / Q000592:standards*; D010356:Patient Isolation; D011159:Population Surveillance; D013211:Staphylococcus aureus / Q000187:drug effects; D014481:United States; D020713:Vancomycin Resistance